Pharma Focus Asia
Eppendorf Bioprocess Solutions

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Vaxxas Announces Interim Results from Phase I Clinical Study of First Needle-Free COVID-19 Vaccine Delivered Using Proprietary High-Density Microarray Patch (HD-MAP)

Tuesday, June 06, 2023

Vaxxas a clinicalstage biotechnology company commercializing a novel vaccination platform today announced positive interim results from a Phase I human clinical trial with the first needlefree COVID vaccine candidate delivered using Vaxxas proprietar...

Ractigen Therapeutics Announces Dosing of First Patient in First in Human Trial of RAG-17 for the Treatment of SOD1-ALS

Tuesday, June 06, 2023

Ractigen Therapeutics a biopharmaceutical company focused on the discovery development and commercialization of novel oligonucleotide therapeutics today announced the dosing of its first patient in the Companys First in Human FIH clinical trial for A...

Daewoong Pharmaceutical Regaining Rights to Fexuprazan in the United States and Canada upon Termination of License Agreement with Neurogastrx

Tuesday, June 06, 2023

Daewoong Pharmaceutical CEO Jeon Sengho Lee Changjae today announced that it and Neurogastrx have agreed to terminate the June license agreement which granted Neurogastrx exclusive right to develop and commercialize Fexuprazan with respect to the US...

Chimeric announces launch of new phase 1b glioblastoma clinical trial

Monday, June 05, 2023

Chimeric Therapeutics ASXCHM Chimeric or the Company the only clinical stage cell therapy company on the ASX is pleased to announce activation of a Phase B clinical trial in patients with recurrent and or progressive glioblastoma multiforme GBM to as...

Dr. Reddy’s successfully completes Phase I study (IV route) of DRL_TC, a proposed biosimilar of tocilizumab

Monday, June 05, 2023

Dr Reddys Laboratories Ltd BSE NSE DRREDDY NYSE RDY NSEIFSC DRREDDY hereafter referred to as Dr Reddys a global pharmaceutical company announced that its tocilizumab biosimilar candidate DRLTC successfully met its primary and secondary endpoints in...

Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region

Saturday, May 20, 2023

Thermo Fisher Scientific the world leader in serving science has opened a new sterile drug facility in Singapore that will better enable customers to deliver new medicines and vaccines in the AsiaPacific market The new facility also marks a significa...

NMPA accepted Akeso's ebronucimab (PCSK9) marketing application in two indications

Saturday, June 03, 2023

Akeso Inc HK Akeso announced today that Chinas National Medical Products Administration NMPA has accepted its New Drug Application NDA for its fully human antiPCSK monoclonal antibody ebronucimab AK for indications primary hypercholesterolemia and...

Pharmaessentia Selects Pint-pharma As Commercial Partner For Besremi® (Ropeginterferon Alfa-2b-njft) In Latin America

Saturday, June 03, 2023

PharmaEssentia Corporation TPEx a leading fully integrated biopharmaceutical company in Taiwan today announced that it has entered into an exclusive license agreement with PintPharma GmbH for the registration and promotion of BESREMi ropeginterferon...

Bruker Introduces Next-Generation Automated BioAFM for Quantification of Molecular Forces

Wednesday, May 31, 2023

Bruker has announced the release of the ForceRobot BioAFM which marks a new milestone in force measurement capabilities It sets new standards in automation generating over force curves per day to deliver the statistically significant datasets requi...

BioLight announces a joint cooperation agreement with Alexion (AstraZeneca Rare Disease) to explore an innovative technology based on natural tears for the diagnosis of retinal diseases

Wednesday, May 31, 2023

BioLight TASE BOLT is proud to report it has signed a research collaboration agreement with Alexion AstraZeneca Rare Disease focusing on exploring a groundbreaking technology that utilizes natural tears for the potential diagnosis of retinal diseases

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACPHI Korea 2023Bora Pharmaceutical - A robust approach to analytical testing is essentialSelangor International Expo MEDIC 2023TFS - Webinar - DynaSpin™ Single-Use Centrifuge for harvest applicationsMedical Fair Thailand 2023ThermoFisher Scientific - NEW Mobile AppCPHI & PMEC China 20233rd ANNUAL COMPUTER SOFTWARE ASSURANCE 2023Pharma Regulatory Conclave 202320th Anniversary Hospitalog Asia 2023
Charles River Laboratories - Endosafe Compendial LAL Cartridge Technology